Michelson Diagnostics makes VivoSight, an optical coherence tomography scanner for skin that shows a cross-section of a lesion a millimetre or two deep, used to diagnose and measure basal cell carcinoma.
Michelson Diagnostics, founded in 2006 in Kent, developed the VivoSight multi-beam OCT scanner and its dynamic OCT mode that shows blood vessels. It is used in dermatology clinics in Europe and the United States for diagnosing basal cell carcinoma, guiding treatment choice and monitoring topical or photodynamic therapy.
Shares Confocal microscopy and optical coherence tomography for skin (VivaScope, VivoSight, deepLive), Basal cell carcinoma, Skin cancer (all types) and the tag machines-wave2.
Shares Confocal microscopy and optical coherence tomography for skin (VivaScope, VivoSight, deepLive), Basal cell carcinoma and the tag machines-wave2.
Shares Confocal microscopy and optical coherence tomography for skin (VivaScope, VivoSight, deepLive), Skin cancer (all types) and the tag machines-wave2.
Shares Confocal microscopy and optical coherence tomography for skin (VivaScope, VivoSight, deepLive), Skin cancer (all types) and the tag machines-wave2.
Shares Confocal microscopy and optical coherence tomography for skin (VivaScope, VivoSight, deepLive) and the tag machines-wave2.
Shares Basal cell carcinoma, Skin cancer (all types) and the tag machines-wave2.
Shares Basal cell carcinoma, Skin cancer (all types) and the tag machines-wave2.
Shares Confocal microscopy and optical coherence tomography for skin (VivaScope, VivoSight, deepLive), Basal cell carcinoma, Skin cancer (all types) and the tag machines-wave2.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/